199 related articles for article (PubMed ID: 31409896)
21. Kangxianruangan granule‑containing serum mediated inhibition of hepatic oval cell differentiation into hepatocellular carcinoma cells via the Wnt‑1/β‑catenin signaling pathway.
Tang W; Xue J; Luo L; Wang Y; Cai X; Liu Y; Huang D; Wang X; He T; Lu D; Yang F
Mol Med Rep; 2022 Feb; 25(2):. PubMed ID: 34913065
[TBL] [Abstract][Full Text] [Related]
22. ATXN7L3B promotes hepatocellular carcinoma stemness and is downregulated by metformin.
Chen B; Cha JH; Yan M; Cao N; Ye P; Yan X; Yang WH
Biochem Biophys Res Commun; 2021 Oct; 573():1-8. PubMed ID: 34375763
[TBL] [Abstract][Full Text] [Related]
23. Metformin Actions on the Liver: Protection Mechanisms Emerging in Hepatocytes and Immune Cells against NASH-Related HCC.
Zhang Y; Wang H; Xiao H
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34065108
[TBL] [Abstract][Full Text] [Related]
24. Treatment-damaged hepatocellular carcinoma promotes activities of hepatic stellate cells and fibrosis through GDF15.
Dong G; Ma M; Lin X; Liu H; Gao D; Cui J; Ren Z; Chen R
Exp Cell Res; 2018 Sep; 370(2):468-477. PubMed ID: 30146065
[TBL] [Abstract][Full Text] [Related]
25. [Observation on experimental liver fibrosis and hepatic carcinogenesis of HBV gene knock-in transgenic mice induced by CCl4/ethanol].
Xu XB; Leng XS; He ZP; Chen L; Zhang HY; Zhang HY; Zhang H; Xiao M; Liu CL; Feng ZQ
Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(12):822-5. PubMed ID: 20450621
[TBL] [Abstract][Full Text] [Related]
26. High-saturate-fat diet delays initiation of diethylnitrosamine-induced hepatocellular carcinoma.
Duan XY; Pan Q; Yan SY; Ding WJ; Fan JG; Qiao L
BMC Gastroenterol; 2014 Nov; 14():195. PubMed ID: 25410681
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of c-myc in hepatocytes promotes activation of hepatic stellate cells and facilitates the onset of liver fibrosis.
Nevzorova YA; Hu W; Cubero FJ; Haas U; Freimuth J; Tacke F; Trautwein C; Liedtke C
Biochim Biophys Acta; 2013 Oct; 1832(10):1765-75. PubMed ID: 23770341
[TBL] [Abstract][Full Text] [Related]
28. Predictive and preventive significance of AMPK activation on hepatocarcinogenesis in patients with liver cirrhosis.
Yang X; Liu Y; Li M; Wu H; Wang Y; You Y; Li P; Ding X; Liu C; Gong J
Cell Death Dis; 2018 Feb; 9(3):264. PubMed ID: 29449537
[TBL] [Abstract][Full Text] [Related]
29. ALDH2 deficiency promotes alcohol-associated liver cancer by activating oncogenic pathways via oxidized DNA-enriched extracellular vesicles.
Seo W; Gao Y; He Y; Sun J; Xu H; Feng D; Park SH; Cho YE; Guillot A; Ren T; Wu R; Wang J; Kim SJ; Hwang S; Liangpunsakul S; Yang Y; Niu J; Gao B
J Hepatol; 2019 Nov; 71(5):1000-1011. PubMed ID: 31279903
[TBL] [Abstract][Full Text] [Related]
30. PSMP/MSMP promotes hepatic fibrosis through CCR2 and represents a novel therapeutic target.
She S; Wu X; Zheng D; Pei X; Ma J; Sun Y; Zhou J; Nong L; Guo C; Lv P; Song Q; Zheng C; Liang W; Huang S; Li Q; Liu Z; Song Z; Li Y; Zhang Y; Kong W; You H; Xi J; Wang Y
J Hepatol; 2020 Mar; 72(3):506-518. PubMed ID: 31813573
[TBL] [Abstract][Full Text] [Related]
31. Protective effects of dieckol on N-nitrosodiethylamine induced hepatocarcinogenesis in rats.
Sadeeshkumar V; Duraikannu A; Ravichandran S; Fredrick WS; Sivaperumal R; Kodisundaram P
Biomed Pharmacother; 2016 Dec; 84():1810-1819. PubMed ID: 27825803
[TBL] [Abstract][Full Text] [Related]
32. Genetic and epigenetic changes in fibrosis-associated hepatocarcinogenesis in mice.
Chappell G; Kutanzi K; Uehara T; Tryndyak V; Hong HH; Hoenerhoff M; Beland FA; Rusyn I; Pogribny IP
Int J Cancer; 2014 Jun; 134(12):2778-88. PubMed ID: 24242335
[TBL] [Abstract][Full Text] [Related]
33. Potential Molecular Targets of Statins in the Prevention of Hepatocarcinogenesis.
Ridruejo E; Romero-Caími G; Obregón MJ; Kleiman de Pisarev D; Alvarez L
Ann Hepatol; 2018; 17(3):490-500. PubMed ID: 29735800
[TBL] [Abstract][Full Text] [Related]
34. NADPH Oxidase 1 in Liver Macrophages Promotes Inflammation and Tumor Development in Mice.
Liang S; Ma HY; Zhong Z; Dhar D; Liu X; Xu J; Koyama Y; Nishio T; Karin D; Karin G; Mccubbin R; Zhang C; Hu R; Yang G; Chen L; Ganguly S; Lan T; Karin M; Kisseleva T; Brenner DA
Gastroenterology; 2019 Mar; 156(4):1156-1172.e6. PubMed ID: 30445007
[TBL] [Abstract][Full Text] [Related]
35. Liver haploinsufficiency of RuvBL1 causes hepatic insulin resistance and enhances hepatocellular carcinoma progression.
Mello T; Materozzi M; Zanieri F; Simeone I; Ceni E; Bereshchenko O; Polvani S; Tarocchi M; Marroncini G; Nerlov C; Guasti D; Bani D; Pinzani M; Galli A
Int J Cancer; 2020 Jun; 146(12):3410-3422. PubMed ID: 31721195
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-Based Prophylaxis in a Mouse Model of Cirrhosis and Liver Cancer.
Callegari E; Domenicali M; Shankaraiah RC; D'Abundo L; Guerriero P; Giannone F; Baldassarre M; Bassi C; Elamin BK; Zagatti B; Ferracin M; Fornari F; Altavilla G; Blandamura S; Silini EM; Gramantieri L; Sabbioni S; Negrini M
Mol Ther Nucleic Acids; 2019 Mar; 14():239-250. PubMed ID: 30641476
[TBL] [Abstract][Full Text] [Related]
37. Docetaxel-carboxymethylcellulose nanoparticles ameliorate CCl
Chang CC; Yang Y; Gao DY; Cheng HT; Hoang B; Chao PH; Chen LH; Bteich J; Chiang T; Liu JY; Li SD; Chen Y
J Drug Target; 2018; 26(5-6):516-524. PubMed ID: 29251522
[TBL] [Abstract][Full Text] [Related]
38. The Synthetic Triterpenoid RTA 405 (CDDO-EA) Halts Progression of Liver Fibrosis and Reduces Hepatocellular Carcinoma Size Resulting in Increased Survival in an Experimental Model of Chronic Liver Injury.
Getachew Y; Cusimano FA; Gopal P; Reisman SA; Shay JW
Toxicol Sci; 2016 Jan; 149(1):111-20. PubMed ID: 26443840
[TBL] [Abstract][Full Text] [Related]
39. Metformin mitigates carbon tetrachloride-induced TGF-β1/Smad3 signaling and liver fibrosis in mice.
Fan K; Wu K; Lin L; Ge P; Dai J; He X; Hu K; Zhang L
Biomed Pharmacother; 2017 Jun; 90():421-426. PubMed ID: 28390311
[TBL] [Abstract][Full Text] [Related]
40. Branched-chain amino acids prevent hepatic fibrosis and development of hepatocellular carcinoma in a non-alcoholic steatohepatitis mouse model.
Takegoshi K; Honda M; Okada H; Takabatake R; Matsuzawa-Nagata N; Campbell JS; Nishikawa M; Shimakami T; Shirasaki T; Sakai Y; Yamashita T; Takamura T; Tanaka T; Kaneko S
Oncotarget; 2017 Mar; 8(11):18191-18205. PubMed ID: 28212548
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
